Challenging Case Studies are presented by trainees or technologists. They will discuss the case's clinical history, molecular analysis, interesting features, and the proposed diagnosis. Other molecular testing methods, if applicable, will be included in the presentation, including biopsies, gross/microscopic pathology, immunohistochemistry/flow cytometry, and cytogenetic findings.
Compound EGFR and BRAF variants in NSCLC against the backdrop of suspected MEN2A
Jeremy Adler, MD, Pennsylvania Hospital, UPHS, Philadelphia, PA, USA
Expanded Next Generation Sequencing Panel Detects A Rare EGFR Kinase Domain Duplication In A Patient with Metastatic Lung Cancer
Jong Kim, MD, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Pitfalls in Identification of Mismatch Repair Deficiency: An Unusual Pulmonary Intimal Sarcoma.
Wanying Zhang, MD, New York Presbyterian Hospital, New York, NY, USA
EGFR-Mutated Lung Adenocarcinoma with Early Resistance to Osimertinib
Brennan Decker, MD, PhD, Brigham and Women's Hospital, Boston, MA, USA
Objectives:
- Describe the context of a challenging clinical case.
- Discuss the molecular pathology techniques used in the diagnosis of the case.
- Propose a final diagnosis based upon findings and diagnostic evidence.
Duration: 1.00 hr
Recording Date: November 7, 2019
CME/CMLE credit: 1.00 hr
Last day to purchase course and claim credit: December 24, 2022
